RESEARCH
Advancing Endometrial Cancer Research
Research can transform how we detect, treat, and understand endometrial cancer.
Research is central to the Endometrial Cancer Research Foundation (ECRF) and our mission to improve care and create a better future for those affected by endometrial cancer.
Founded by individuals directly affected by the disease, ECRF believes greater research support is essential to scientific progress and to addressing the needs, gaps, and challenges of endometrial cancer.
Why Endometrial Cancer Research Matters
Endometrial cancer is the most common gynecologic cancer in the United States.
While research has led to important progress in understanding endometrial cancer and expanding treatment options, major challenges persist, particularly in early detection and improving management of advanced or recurrent disease.
Ongoing research is crucial to deepen our understanding of the disease, advance treatment outcomes, address disparities in care, increase diversity in clinical trials, and meet the long-term needs of patients and survivors.
The Need for Research by Numbers:
68,270
Estimated new cases of uterine corpus cancer in the U.S. in 2026.
14,450
Estimated deaths from uterine corpus cancer in the U.S. in 2026.
2x
Estimated death rate in black women compared to white women, due to unequal access to quality care.
Source: ACS, Cancer Facts & Figures 2026Our Commitment to Research.
Where More Research Is Needed
Scientific advances have expanded treatment options, but significant gaps remain in understanding and managing endometrial cancer.
Our commitment and priorities for endometrial cancer research:
Earlier detection and timely diagnosis
More effective treatments for advanced and recurrent disease
Personalized treatment through molecular testing and biomarkers
Greater and more equitable access to care and clinical trials
Improved survivorship and quality of life
ECRF aims to support research that opens new possibilities for scientific discovery and better outcomes for those affected by endometrial cancer.
Research In Action
Introducing ECRF's First Seed-Funded Research Project
ECRF's first seed-funded research project supports work led by Anicka AbiChedid, a Ph.D. candidate in Duke University's Cell and Molecular Biology program.
Her project aims to develop a less invasive blood-based method to detect endometrial cancer at an earlier stage in women with Lynch syndrome. This inherited condition increases their risk of developing the disease.
A Vision for Endometrial Cancer Research
Every advancement in endometrial cancer research begins with a commitment to asking questions, challenging what we know, and exploring what is possible. This commitment drives ECRF's belief that supporting research today can open doors to discoveries shaping better care and outcomes for generations to come.
Our work is possible because of the generosity and commitment of our donors, volunteers, partners, advocates, and the growing ECRF Peach Community.
Thank you for helping us build a stronger foundation for endometrial cancer research. Continue supporting our mission so we can advance progress for those affected by endometrial cancer.
Corby Arthur
Founder & President, ECRF